Literature DB >> 15133539

A case of risperidone-induced hypothermia.

Mohammad Razaq1, Muneeb Samma.   

Abstract

Risperidone is one of the second-generation antipsychotics (SGAs). Use of SGAs or so-called atypical antipsychotics is becoming more frequent because they are more efficacious and safer than typical antipsychotics. This is due to their ability to occupy some other receptors as well as dopamine type 2 (D(2)) receptors in the brain. Risperidone has more affinity for serotonin type 2 (5-HT(2)) than for D(2) receptors. This accounts for its better treatment of negative symptoms of schizophrenia and fewer extrapyramidal side effects when compared with typical antipsychotics. Common side effects associated with risperidone include extrapyramidal symptoms, dizziness, nausea, weight gain, sleep disturbance, and sexual dysfunction. We describe here a case of risperidone-induced hypothermia. Body temperature is regulated by the preoptic anterior hypothalamus with involvement of dopamine, serotonin, norepinephrine, and alpha-adrenergic receptors. Experimental data suggest that stimulation of 5-HT(2) and dopamine receptors can increase the body temperature. Additional clinical evidence indicates potent antagonists of 5-HT(2) are more likely to cause hypothermia. Risperidone has higher potency for occupying 5-HT(2) than D(2) receptors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15133539     DOI: 10.1097/00045391-200405000-00012

Source DB:  PubMed          Journal:  Am J Ther        ISSN: 1075-2765            Impact factor:   2.688


  10 in total

Review 1.  De Novo delayed onset hypothermia secondary to therapeutic doses of risperidone in bipolar affective disorder.

Authors:  M A Lasitha Perera; Jegan Yogaratnam
Journal:  Ther Adv Psychopharmacol       Date:  2014-04

2.  Case report of valproate-induced hypothermia in a patient with schizoaffective disorder.

Authors:  Matthew R Tubb; Christopher C White; Patricia R Wigle
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

3.  Thermoregulation and the role of calcium signalling in neurotransmission.

Authors:  Atmaram Yarlagadda; Anita H Clayton
Journal:  Psychiatry (Edgmont)       Date:  2008-12

Review 4.  Functional Changes of Orexinergic Reaction to Psychoactive Substances.

Authors:  Vincenzo Monda; Monica Salerno; Francesco Sessa; Renato Bernardini; Anna Valenzano; Gabriella Marsala; Christian Zammit; Roberto Avola; Marco Carotenuto; Giovanni Messina; Antonietta Messina
Journal:  Mol Neurobiol       Date:  2018-01-06       Impact factor: 5.590

5.  Hypothermia secondary to ziprasidone use in a man with schizophrenia.

Authors:  Roopa Sethi; Bush Kavuru
Journal:  Prim Care Companion CNS Disord       Date:  2012-08-16

6.  Risperidone alters food intake, core body temperature, and locomotor activity in mice.

Authors:  Mark B Cope; Xingsheng Li; Patricia Jumbo-Lucioni; Catherine A DiCostanzo; Wendi G Jamison; Robert A Kesterson; David B Allison; Tim R Nagy
Journal:  Physiol Behav       Date:  2008-11-27

Review 7.  Hypothermia following antipsychotic drug use.

Authors:  Rob J van Marum; Michelle A Wegewijs; Anton J M Loonen; Erna Beers
Journal:  Eur J Clin Pharmacol       Date:  2007-03-31       Impact factor: 2.953

8.  Hypothermia due to Antipsychotic Medication: A Systematic Review.

Authors:  Cherryl Zonnenberg; Jolien M Bueno-de-Mesquita; Dharmindredew Ramlal; Jan Dirk Blom
Journal:  Front Psychiatry       Date:  2017-09-07       Impact factor: 4.157

9.  Thermoregulation and altered calcium signaling: a side-effect of antipsychotic drugs?

Authors:  Mohammad Osama Anwer; Mustafa Abbas; Muhammad Danish Saleem
Journal:  Indian J Psychol Med       Date:  2014-01

10.  Risperidone Treatment after Transient Ischemia Induces Hypothermia and Provides Neuroprotection in the Gerbil Hippocampus by Decreasing Oxidative Stress.

Authors:  Go Eun Yang; Hyun-Jin Tae; Tae-Kyeong Lee; Young Eun Park; Jeong Hwi Cho; Dae Won Kim; Joon Ha Park; Ji Hyeon Ahn; Sungwoo Ryoo; Young-Myeong Kim; Myoung Cheol Shin; Jun Hwi Cho; Choong-Hyun Lee; In Koo Hwang; Hui Jin; Moo-Ho Won; Jae-Chul Lee
Journal:  Int J Mol Sci       Date:  2019-09-18       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.